Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Bio-Rad Introduces First ProteOn™ Sensor Chip

Published: Thursday, May 24, 2012
Last Updated: Thursday, May 24, 2012
Bookmark and Share
Product capable of label-free interaction analysis of membrane proteins with peptides and small molecules.

Drug Discovery Researchers Get Powerful Tool for Screening Membrane Targets.

Bio-Rad Laboratories, Inc. announced the launch of two surface plasmon resonance (SPR) kits that, when used with the ProteOn XPR36 protein interaction analysis system, enable for the first time the accurate analysis of lipids and membrane proteins with peptides and small molecules.

G-coupled protein receptors, 7-transmembrane receptors, and other integral membrane proteins constitute more than 40% of new drug targets. The new kits — the novel hydrophilic ProteOn LCP liposome capturing kit and the lipophilic ProteOn GLC lipid kit — stably and selectively capture lipids and lipid assemblies for easier screening and analysis of membrane protein targets during drug discovery.

ProteOn_LCP_Capturning_Reag.gif

ProteOn LCP Liposome Capturing Kit

The ProteOn LCP sensor employs memLayer technology to selectively and stably capture lipid assemblies. The “native-lipid like” environment of the chip surface where proteins are captured ensures high quality data.

"The memLayer approach offers an interesting alternative,” said Maria Pavlaki, a senior researcher at Democritus University of Thrace in Greece. “The proteins can be in a more native-like environment (lipoparticles or liposomes) that resembles the cell membrane and are not ‘squashed’ on the surface.”

Capable of capturing multiple layers of lipid assemblies, the ProteOn LCP liposome capturing kit SPR kit is the first to allow label-free detection for binding analysis of peptides and small molecules. And, it empowers researchers to gauge drug absorption by monitoring interactions at the lipid’s surface and tracking uptake of molecules into the assembly.

The ProteOn LCP capturing reagent kit, included in the ProteOn LCP liposome capturing kit, is used to activate the LCP sensor chip with a biotinylated DNA tag that then hybridizes to DNA-tagged lipid assemblies containing membrane proteins of interest.

The surface is easily regenerated with water and ready for re-use.

ProteOn GLC Lipid Kit

The ProteOn GLC lipid kit provides researchers with a basic, easy-to-use option to study interactions of membranes with proteins and peptides. Biopharmaceutical researchers use the kit to capture lipoparticles containing membrane protein drug targets of interest. Antibodies against those drug targets are then screened to measure binding kinetics, an important step in biotherapeutic development.

Researchers can customize the lipophilicity of the GLC sensor surface before capturing lipid assemblies (e.g. proteoliposomes and lipoparticles) by controlling the amount of alkylamine that is bound to the sensor surface. This provides greater experimental flexibility and, because the surface is stable and regenerable, researchers have greater confidence in the quality of data collected over the course of a screening protocol.

"I am very happy with the GLC lipid kit,” said Fang Yi, Ph.D., a scientist at Janssen Biotech “It’s rather straightforward, with very stable capture, high capacity, reproducibility, and also low non-specific binding. I would definitely like to use it for my future lipoparticle characterization studies.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pilot Project to Generate Affinity Reagents to Human Proteins Chooses ProteOn Xpr36
University of Toronto selected the ProteOn to screen for binding affinities of reagents, as part of an international consortium pilot study.
Monday, February 02, 2009
Bio-Rad Study Describes Evaluation of Cancer Biomarkers
Bio-Rad researchers evaluated the Bio-Plex® suspension array system’s ability to detect the levels of nine biomarkers.
Wednesday, June 11, 2008
Bio-Rad Announces Web Seminar Series
Bio-Rad's second series of web seminars beginning in August will focus on the latest approaches in metabolomics, spectroscopy and ADME/Tox.
Thursday, July 20, 2006
Bio-Rad Announced the Capability of its MicroRotofor™
The instrument enables scientists to enrich low abundance proteins for biomarker discovery.
Wednesday, July 12, 2006
Bio-Rad Announces Web Seminar Series
Web seminar series area includes Spectroscopy, Chromatography, ADME/Tox and Metabolomics.
Friday, May 05, 2006
Scientific News
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
A Metabolic Twist that Drives Cancer Survival
A novel metabolic pathway that helps cancer cells thrive in conditions that are lethal to normal cells has been identified.
Liver-On-Chip Tracks Dynamics of Cellular Function
Hebrew University’s liver-on-chip platform is uniquely able to monitor metabolic changes indicating mitochondrial damage occurring at drug concentrations previously regarded as safe.
Living Off the Fat of the Land
Do cancer cells synthesize the parts for new cells or scavenge them from the environment?
Liver Disease, Obesity Linked
Kanazawa University researchers find similarities in the impeded signalling between central insulin activity and glucose production in the liver for both obese mice and mice that have had the vagus nerve removed.
Decoding Ties Between Vascular Disease, Alzheimer’s
NIH consortium uses big data, team science to uncover complex interplay of factors.
Gene Identified that May Worsen Cancer Outcome
Some patients with breast cancer, lung cancer and leukaemia seem to fare poorly after treatment because of the effects of a particular gene, a new study finds.
‘Big Data’ Drills Down Into Metabolic Details
Rice University bioengineers introduce efficient way to analyze, compare tissue-specific pathways.
New Approach to Curbing Cancer Cell Growth
Using a new approach, scientists at The Scripps Research Institute (TSRI) and collaborating institutions have discovered a novel drug candidate that could be used to treat certain types of breast cancer, lung cancer and melanoma.
New Drug Delivery Method for Pancreatic Cancer
UCLA researchers use nanoparticles to send chemotherapy drug directly to the tumor site, reducing damage to healthy tissues.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!